Stevens Capital Management LP Trims Holdings in Healthpeak Properties, Inc. $DOC

Stevens Capital Management LP lowered its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 57.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,100 shares of the real estate investment trust’s stock after selling 13,478 shares during the quarter. Stevens Capital Management LP’s holdings in Healthpeak Properties were worth $177,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Healthpeak Properties by 584.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock valued at $186,405,000 after purchasing an additional 7,872,150 shares during the period. Nuveen LLC purchased a new stake in Healthpeak Properties in the 1st quarter worth $124,113,000. Invesco Ltd. raised its holdings in Healthpeak Properties by 20.7% during the first quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock valued at $467,311,000 after acquiring an additional 3,967,830 shares during the period. Nordea Investment Management AB lifted its position in shares of Healthpeak Properties by 7,444.0% in the second quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock valued at $67,871,000 after acquiring an additional 3,871,201 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Healthpeak Properties by 21.5% in the second quarter. JPMorgan Chase & Co. now owns 20,024,030 shares of the real estate investment trust’s stock valued at $350,621,000 after acquiring an additional 3,540,367 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Trading Up 2.5%

DOC stock opened at $17.83 on Monday. The firm has a fifty day moving average price of $18.29 and a 200 day moving average price of $17.83. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $22.71. The firm has a market cap of $12.39 billion, a PE ratio of -356.53, a price-to-earnings-growth ratio of 3.84 and a beta of 1.10. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.28 and a current ratio of 1.22.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The company had revenue of $705.87 million for the quarter, compared to the consensus estimate of $681.65 million. During the same quarter in the prior year, the firm earned $0.45 earnings per share. Healthpeak Properties’s revenue was up .8% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 19th will be given a $0.1017 dividend. The ex-dividend date is Friday, December 19th. This represents a c) annualized dividend and a yield of 6.8%. Healthpeak Properties’s dividend payout ratio (DPR) is currently -2,440.00%.

Analysts Set New Price Targets

Several analysts recently issued reports on DOC shares. Raymond James Financial raised Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a research note on Monday, September 15th. Cantor Fitzgerald began coverage on shares of Healthpeak Properties in a research report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective on the stock. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Morgan Stanley reduced their price target on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, August 22nd. Finally, Wells Fargo & Company decreased their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 27th. Seven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Healthpeak Properties currently has an average rating of “Moderate Buy” and an average price target of $20.82.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.